Evidence map›Paper›PMID 38019145›Full record

ArticleLab on a chip2023

Micropillar enhanced FRET-CRISPR biosensor for nucleic acid detection.

Mengdi Bao, Stephen J Dollery, Fnu Yuqing, Gregory J Tobin, Ke Du

Open access · greenAbstract read
In one paragraph

Article in Lab on a chip, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mengdi BaoDepartment of Chemical and Environmental Engineering, University of California, Riverside, CA, USA. ke.du@ucr.edu.ORCID http://orcid.org/0000-0002-5460-9503
Stephen J DolleryBiological Mimetics, Inc., 124 Byte Drive, Frederick, MD 21702, USA.
Fnu YuqingDepartment of Chemical and Environmental Engineering, University of California, Riverside, CA, USA. ke.du@ucr.edu.
Gregory J TobinBiological Mimetics, Inc., 124 Byte Drive, Frederick, MD 21702, USA.
Ke DuDepartment of Chemical and Environmental Engineering, University of California, Riverside, CA, USA. ke.du@ucr.edu.ORCID http://orcid.org/0009-0005-5194-281X
University of California, Riverside · USBiological Mimetics (United States) · US

Funding

Understand and Detect Sepsis: Pathogen Isolation, Biochemistry Assay, and Optofluidic SensingR35GM142763 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI DU, KE · 2021 to 2025
$2.0M
NIGMS NIH HHS R35 GM142763
6 · The paper itself

Abstract

CRISPR technology has gained widespread adoption for pathogen detection due to its exceptional sensitivity and specificity. Although recent studies have investigated the potential of high-aspect-ratio microstructures in enhancing biochemical applications, their application in CRISPR-based detection has been relatively rare. In this study, we developed a FRET-based biosensor in combination with high-aspect-ratio microstructures and Cas12a-mediated trans-cleavage for detecting HPV 16 DNA fragments. Remarkably, our results show that micropillars with higher density exhibit superior molecular binding capabilities, leading to a tenfold increase in detection sensitivity. Furthermore, we investigated the effectiveness of two surface chemical treatment methods for enhancing the developed FRET assay. A simple and effective approach was also developed to mitigate bubble generation in microfluidic devices, a crucial issue in biochemical reactions within such devices. Overall, this work introduces a novel approach using micropillars for CRISPR-based viral detection and provides valuable insights into optimizing biochemical reactions within microfluidic devices.

Indexed as

Biosensing TechniquesNucleic AcidsBiological AssayCRISPR-Cas SystemsFluorescence Resonance Energy TransferLab-On-A-Chip DevicesTechnologyNucleic Acids

Identifiers

PMID38019145
PMCPMC11221459
OpenAlexW4388837944

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.